TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NIH Alternative Medicine Officer Under Fire For Proposed RFA In Homeopathy, Acupuncture February 26, 1993